51828-34-3 Usage
Chemical structure
A derivative of 1-benzothiophene with a fluorine atom at the 5th position and a methyl group at the 3rd position.
Potential pharmaceutical properties
Due to its unique chemical structure, it may have diverse biological activities and pharmacological effects.
Fluorine and methyl groups
These groups in the chemical structure may contribute to its pharmacological effects and potential therapeutic applications.
Therapeutic applications
It has the potential to be used in the development of new drugs for various therapeutic applications.
Neurological and psychiatric disorders
It may be used in the treatment of neurological and psychiatric disorders due to its potential pharmacological properties.
Cancer treatment
It may have potential applications in cancer treatment, although further research is needed to confirm its effectiveness.
Infectious diseases
It may also be used in the treatment of infectious diseases, given its potential pharmacological properties.
Further research and development
More research and development are needed to fully understand the pharmacological properties and potential uses of this compound.
Check Digit Verification of cas no
The CAS Registry Mumber 51828-34-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,1,8,2 and 8 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 51828-34:
(7*5)+(6*1)+(5*8)+(4*2)+(3*8)+(2*3)+(1*4)=123
123 % 10 = 3
So 51828-34-3 is a valid CAS Registry Number.
51828-34-3Relevant articles and documents
Synthesis of Thia-Analogues of Calothrixin B Involving FeCl3-Mediated Domino Reaction
Ramalingam, Bose Muthu,Moorthy, Nachiappan Dhatchana,Vellaichamy, Elangovan,Mohanakrishnan, Arasambattu K.
supporting information, p. 133 - 137 (2016/12/26)
The total synthesis of thiacalothrixins, an isostere of the biologically important carbazoloquinone alkaloid calothrixin B, was achieved from ethyl benzo[b]thiophene-2-carboxylate. Alternatively, the multi-step synthesis of thiaisocalothrixins could be achieved from 3-methylbenzo[b]thiophene. A preliminary in vitro cytotoxicity evaluation of the synthesized thia analogues of calothrixins displayed promising potential against cancer cell cultures.
Fused ring compounds, process for producing the same and use thereof
-
, (2008/06/13)
To provide a novel compound of the formula: [wherein A1 ix a 5 or 6-membered ring which may be substituted by a group not containing a cyclic group, A2 is an aromatic ring which may be substituted, X is a divalent group, Y is a nitrogen atom or a methine group, Z is an ethenylene which may be substituted or ethynylene, R is a heterocyclic group which may be substituted, provided that 3,4-dihydro-6-[3-(1H-imidazol-1-yl)-1-propenyl]-2(1H)-quinolone and 2-[3-[5-ethyl-6-methyl-2-(benzyloxy)-3-pyridyl]-1-propenyl]benzoxazole are excluded.], or a salt thereof which has steroid C17,20-lyase inhibitory activity, and is useful for preventing and treating mammals suffering from, for example, primary cancer of malignant tumor, its metastasis and recurrence thereof.
